First Placebo-Controlled Trial Finds Cannabis More Effective For Treating Migraine
A balanced CBD and THC cannabis flower was found to be more effective for treating acute migraine symptoms than a placebo.
24 results for “placebo”
A balanced CBD and THC cannabis flower was found to be more effective for treating acute migraine symptoms than a placebo.
A new study sheds light on the impact of the placebo effect and pain relieving benefits of CBD.
Some scientists believe medical cannabis and CBD may have a placebo effect – although that’s not necessarily a bad thing. The placebo effect has long fascinated scientists. Countless studies have […]
Ask any UK cannabis clinic which conditions bring people through the door, and ADHD will reliably be near the top of the list. Despite this demand, the published literature on […]
In a first-of-its-kind clinical trial, researchers found that people who took THC and CBD had significantly less agitation compared to people who received a placebo.
Exilby® has received market authorisation in Germany and Austria, with UK approval expected by the end of the year.
The development puts VER-01 in prime position to become the first FDA-approved cannabis-derived medicine for pain.
ADHD is one of the most commonly reported reasons people seek medical cannabis, but does the evidence support it?
People who consumed THC were more likely to recall words that were never shown to them.
A small pilot study suggests Epidiolex may have benefits for weight restoration and symptom improvement in anorexia patients.
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
The company has cleared the final regulatory hurdle to begin its ENDOCAN Phase 2 trial in women with endometriosis-associated pain.
Early research suggests CBG-A could support cardiovascular health and reduce oxidative stress.
A comprehensive guide on how to read and interpret cannabis research.
Adults with chronic pain who participated in New York State’s (NYS) Medical Cannabis Program were significantly less likely to require prescription opioids, according to a new study. The study, published […]
We examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry.
A number of studies have explored whether medicinal cannabis could be used to treat some of the common symptoms.
Cannabis-based medicines, particularly those containing THC or mixed cannabinoids, may improve sleep quality and ease symptoms of insomnia.
A new clinical trial will investigate the potential of cannabis-based treatment to improve quality of care for hospice eligible patients with dementia.
In the first controlled clinical trial of CBD in boys with autism, two-thirds of participants showed behavioural improvements with treatment.
CBD was linked to meaningful benefits and improved behaviour in children and teenagers with autism spectrum disorder.
Almost 400 families were found to be sourcing illegal cannabis products having been unable to get a prescription on the NHS.
In a new study researchers explored whether CBD can reduce scan-related anxiety in patients with advanced breast cancer.
The FDA has given MAPS the green light to carry out a study in 320 veterans suffering from moderate to severe PTSD.